I. Deconto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
I. Deconto has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- A.T. Gularte
Universidade Federal do Paraná, Brazil
1 shared publication - Andressa Duarte Lorga
Universidade Federal do Paraná, Brazil
1 shared publication - Anny Raissa Carolini Gomes
Universidade de São Paulo
1 shared publication - F.A.P. Amaro
Universidade Federal do Paraná, Brazil
1 shared publication - Mariana Cocco
Programa de Pós-Graduação em Medicina Veterinária, Universidade Federal de Santa Maria, Santa Maria, Brasil
1 shared publication - Peterson Triches Dornbusch
Federal University of Parana
1 shared publication
Latest Publications
- Open Access
- 1 June 2022
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 74 (3) , 509-513
Application of Euphorbia tirucalli sap in sarcoid treatment in horses - case report
Sarcoid is the most common cutaneous neoplasm in horses, with no established therapy, due to the variable neoplastic manifestation and the oscillating individual response to therapies. The Euphorbia tirucalli plant, known as Aveloz, has terpenes and sterols in its latex with antitumor activity, being widely used in popular medicine. Eight horses were referred to the Veterinary Hospital diagnosed with sarcoid, and they were treated only with an aqueous solution containing Euphorbia tirucalli. The most common location of tumors was base of the ear and pectoral; seven of the eight animals had tumors in more than one region. The intratumoral injection containing the sap of Aveloz was applied until the tumor became turgent, visualizing blackening, dryness, and a detachment of the sarcoid in 24 to 72 hours. The use of Euphorbia tirucalli sap showed 87.5% efficacy in the treatment of sarcoids and adverse effects were observed in the seven animals in which the technique was effective. The treated horses were evaluated for three months to seven years, and none had tumor recurrences. The intralesional application of Euphorbia tirucalli sap has been proved to be effective, safe, and low-cost in the treatment of sarcoid in horses, being a viable alternative for this type of cutaneous neoplasm.
- 1 June 2022
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 74 (3) , 509-513
Open AccessApplication of Euphorbia tirucalli sap in sarcoid treatment in horses - case report
Sarcoid is the most common cutaneous neoplasm in horses, with no established therapy, due to the variable neoplastic manifestation and the oscillating individual response to therapies. The Euphorbia tirucalli plant, known as Aveloz, has terpenes and sterols in its latex with antitumor activity, being widely used in popular medicine. Eight horses were referred to the Veterinary Hospital diagnosed with sarcoid, and they were treated only with an aqueous solution containing Euphorbia tirucalli. The most common location of tumors was base of the ear and pectoral; seven of the eight animals had tumors in more than one region. The intratumoral injection containing the sap of Aveloz was applied until the tumor became turgent, visualizing blackening, dryness, and a detachment of the sarcoid in 24 to 72 hours. The use of Euphorbia tirucalli sap showed 87.5% efficacy in the treatment of sarcoids and adverse effects were observed in the seven animals in which the technique was effective. The treated horses were evaluated for three months to seven years, and none had tumor recurrences. The intralesional application of Euphorbia tirucalli sap has been proved to be effective, safe, and low-cost in the treatment of sarcoid in horses, being a viable alternative for this type of cutaneous neoplasm.